Sanyo Of Japan Launches Regenerative Medicine Devices
This article was originally published in PharmAsia News
Japan's Sanyo Electric launched eight different devices for the field of regenerative medicine, including an automated cell culture machine. Other medical equipment includes a high-performance freezer to cool samples rapidly to minus 85 centigrade. The launches signal Sanyo's entrance into the regenerative medicine market in Japan, beyond its dominant role in making industrial freezers for hospitals. Sanyo plans to expand that area of its business to North America and Europe within the next two years. (Click here for more - a subscription may be required
You may also be interested in...
Third quarter earnings show Gilead’s Immunomedics buy paid off, but filgotinib’s path may narrow. The HIV and HCV franchises picked up from their COVID-19 lull.
US pharmacy group says that 10 to 12 states have indicated through an informal survey that they do not have the manpower or funding to implement the US FDA’s final MOU on inordinate compounding. They say what is at stake in these states is patient access to compounded medicines.
Mayo Clinic announces AI-based partnerships with Google and voice-analysis company Vocalis Health this week.